Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain.
Int Rev Cell Mol Biol. 2012;297:175-234. doi: 10.1016/B978-0-12-394308-8.00005-4.
Stem cells have captured the imagination of the general public by their potential as new therapeutic tools in the fight against degenerative diseases. This potential is based on their capability for self-renewal and at the same time for producing progenitor cells that will eventually provide the building blocks for tissue and organ regeneration. These processes are carefully orchestrated in the organism by means of a series of molecular cues. An emerging molecule which is responsible for some of these physiological responses is adrenomedullin, a 52-amino acid regulatory peptide which increases proliferation and regulates cell fate of stem cells of different origins. Adrenomedullin binds to specific membrane receptors in stem cells and induces several intracellular pathways such as those involving cAMP, Akt, or MAPK. Regulation of adrenomedullin levels may help in directing the growth and differentiation of stem cells for applications (e.g., cell therapy) both in vitro and in vivo.
干细胞通过其作为对抗退行性疾病的新治疗工具的潜力,引起了公众的想象力。这种潜力基于其自我更新的能力,同时也能产生祖细胞,最终为组织和器官再生提供构建块。这些过程在生物体中通过一系列分子线索进行精心协调。一种新兴的分子,即肾上腺髓质素,是一种负责其中一些生理反应的分子,它是一种 52 个氨基酸的调节肽,可增加增殖并调节不同来源的干细胞的细胞命运。肾上腺髓质素与干细胞中的特定膜受体结合,并诱导几种细胞内途径,如涉及 cAMP、Akt 或 MAPK 的途径。调节肾上腺髓质素水平可能有助于指导干细胞的生长和分化,以用于体外和体内的应用(例如细胞治疗)。